AdaptHealth Corp.

NASDAQ: AHCO · Real-Time Price · USD
9.48
-0.01 (-0.11%)
At close: Aug 15, 2025, 3:59 PM
9.48
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

AdaptHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.24B 3.05B 3.26B 3.26B 3.26B 3.25B 3.2B 3.12B 2.88B 2.81B 2.77B 2.69B 2.79B 2.68B 2.45B 2.1B 1.73B 1.35B
Cost of Revenue
2.8B 2.57B 2.6B 2.77B 2.78B 2.76B 2.73B 2.72B 2.67B 2.61B 2.55B 2.45B 2.33B 2.21B 2.01B 1.71B 1.42B 1.13B
Gross Profit
437.29M 475.92M 658.33M 493.45M 480M 484.28M 468.07M 400.62M 201.02M 198.73M 218.59M 248.11M 460.58M 469.27M 445.61M 393.17M 313.45M 221.75M
Operating Income
263.58M 242.92M 276.81M 281.4M -243.12M -247.46M -278.34M -353.87M 160.12M 165.04M 190.41M 232.76M 255.52M 261.75M 225.6M 192.28M 129.82M 80.89M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
149.23M 125.29M 136.02M -206.38M -725.9M -733.24M -723.78M -448.94M 61.37M 65.03M 97.9M 128.24M 175.84M 244.13M 190.96M 122.74M 47.87M -35.53M
Net Income
80.59M 85.35M 90.42M -214.34M -691.28M -696.74M -678.89M -425.96M 41.52M 40.38M 62.89M 85.6M 120.28M 179.63M 137.46M 85.28M 34.7M -33.15M
Selling & General & Admin
459.14M 418.71M 380.24M 200.79M 196.74M 189.81M 188.95M 180.25M 175.73M 168.2M 162.13M 159.59M 151.92M 152.32M 167.5M 164.19M 157.49M 131.63M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
607.67M 420.68M 607.67M n/a -3.32M -5.4M 10.13M 26.91M -152.46M -134.5M -133.95M -151.86M 31.28M 13.73M -1.83M -57.56M -53.9M -51.19M
Operating Expenses
438.14M 210.72M 359.24M 200.79M 211.26M 219.87M 234.55M 242.62M 40.9M 33.7M 28.17M 15.35M 205.06M 207.52M 220M 200.9M 183.63M 140.87M
Interest Expense
117.09M 122.59M 126.67M 130.43M 131.3M 130.82M 130.3M 127.32M 123.54M 116.59M 109.41M 104.52M 100.25M 97.79M 95.19M 83.19M 71.34M 55.68M
Selling & Marketing Expenses
n/a n/a n/a -1.14M -1.14M -1.14M -1.14M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.88B 3.42B 3.6B 2.98B 2.99B 2.98B 2.97B 2.96B 2.72B 2.65B 2.58B 2.46B 2.53B 2.42B 2.23B 1.91B 1.6B 1.27B
Income Tax Expense
64.12M 35.48M 41.24M 3.82M -38.83M -40.68M -49M -26.16M 14M 17.45M 24.77M 30.06M 36.63M 40.1M 32.81M 15.56M 2.78M -7.73M
Shares Outstanding (Basic)
134.9M 134.8M 134.57M 134.3M 133.22M 132.91M 132.99M 134.82M 134.29M 134.53M 133.42M 134.23M 134.33M 134.02M 132.47M 131.68M 129.66M 111.11M
Shares Outstanding (Diluted)
137.18M 134.8M 136.53M 136.53M 136.03M 132.91M 132.99M 134.98M 136.23M 135.98M 134.14M 137.58M 137.01M 138.48M 136.38M 140.32M 136.58M 116M
EPS (Basic)
0.55 0.58 0.61 -1.64 -5.17 -5.2 -5.07 -3.17 0.30 0.29 0.46 0.63 0.93 1.40 1.08 0.45 0.01 -0.45
EPS (Diluted)
0.54 0.57 0.60 -1.65 -5.16 -5.2 -5.24 -3.34 0.12 0.12 0.46 0.62 0.72 0.75 0.44 -0.18 -0.43 -0.47
EBITDA
467.07M 624.26M 650.98M 322.25M -179.12M -177.5M -172.09M 154.82M 656.95M 625.7M 633.88M 632.36M 627.41M 633.28M 569.98M 275.12M 138.48M 39.83M
EBIT
187.07M 247.88M 263.09M -75.15M -593.4M -601.23M -592.68M -323.41M 182.71M 180.12M 206.52M 234.15M 277.49M 342.62M 286.15M 164.08M 14.92M -83.45M
Depreciation & Amortization
201.91M 376.38M 387.9M 397.4M 414.29M 423.73M 420.59M 478.23M 470.32M 441.65M 423.44M 394.28M 364.38M 346.65M 309.35M 205.41M 158.33M 112.91M